Nextgen Healthcare Inc - NXGN STOCK NEWS

NextGen Healthcare (NASDAQ: NXGN) has appointed David Sides as President and CEO, emphasizing a focus on future growth. Sides highlights the company's strong market position due to investments in technology and personnel over the last five years, aiming to accelerate growth from mid-single digits to double-digit percentages. He encourages shareholders to vote 'FOR' all proposals on the WHITE proxy card, including director nominations. The company underscores its commitment to enhancing ambulatory care and maintaining a competitive edge in technology solutions.

NextGen Healthcare has filed a presentation with the U.S. Securities and Exchange Commission regarding its 2021 Annual Meeting of Shareholders. The Board of Directors emphasizes the company’s readiness for growth, citing record revenues and a strong sales team. They encourage shareholders to vote for all proposals on the WHITE proxy card to maintain control against dissenting candidate Sheldon Razin. The presentation aims to refute misleading claims about the company's leadership and strategies.

The Razin Group, owning 15.2% of NextGen Healthcare (NASDAQ: NXGN), has released a 70-page presentation highlighting the need for a board overhaul. They criticize the current leadership, particularly Chairman Jeffrey Margolis, for six years of poor performance, including stagnant revenue and deteriorating earnings. The group opposes Margolis' reelection and urges shareholders to vote for their minority slate using the BLUE Proxy Card, aiming to enhance governance and prioritize shareholder value amid proposed changes that could consolidate board power and diminish shareholder rights.

NextGen Healthcare (Nasdaq: NXGN) has partnered with Clinect Healthcare to enhance patient satisfaction through the NextGen Patient Experience Platform. This collaboration enables providers at Care Resource Community Health Centers in South Florida to conduct surveys on patient satisfaction, monitor social media reviews, and analyze patient-reported outcomes. The platform aims to improve patient engagement and health outcomes, as emphasized by Care Resource's increased patient engagement rates during the pandemic.

NextGen Healthcare (NASDAQ: NXGN) announced the approval of inducement awards for David Sides and Srinivas Velamoor following their appointments as President & CEO and Chief Growth & Strategy Officer, respectively. Sides will receive 450,000 performance share units and 640,500 shares of restricted stock. Velamoor is set to receive 397,114 shares of restricted stock. These grants, effective September 22, 2021, are part of the company’s 2021 Employment Inducement Equity Incentive Award Plan, as per NASDAQ rules, aimed at attracting key talent.

NextGen Healthcare (NASDAQ: NXGN) announced the appointment of David Sides as President and CEO, effective September 22. Sides, with over 20 years of experience in healthcare technology, previously served as COO at Teladoc Health, where revenues doubled in 2020. His leadership is expected to enhance NextGen's growth and operational stability. The Board believes Sides' strategic vision aligns with the company’s long-term industry trends. His addition to the slate for the upcoming annual meeting signifies a strengthened management team focused on healthcare technology innovation.

NextGen Healthcare (NASDAQ: NXGN) has partnered with Klamath Tribal Health in Oregon to offer large-scale COVID-19 vaccinations. Utilizing NextGen® Mobile and NextGen® Enterprise, Klamath has successfully conducted numerous mobile vaccination clinics since December 2020, reaching thousands of patients. The partnership enables effective patient engagement and ensures operational efficiency in vaccination processes. This initiative highlights the potential of technology in transforming healthcare delivery.

NextGen Healthcare, Inc. (NASDAQ: NXGN), a leader in ambulatory-focused technology solutions, will participate in the Cantor Virtual Global Healthcare 2021 Conference on September 27, 2021, starting at 8:00 a.m. ET. Management will engage in a fireside chat, which will be accessible via recording on the company's investor relations website for 90 days post-event. NextGen aims to enhance ambulatory care through integrated technology solutions that improve clinical productivity and patient experiences while ensuring positive financial outcomes.

Sheldon Razin and his group, owning 15.2% of NextGen Healthcare (NXGN), filed a proxy statement urging shareholders to elect their slate of directors at the upcoming Annual Meeting on October 13, 2021. They criticize current Chairman Jeffrey Margolis's six-year tenure, noting poor financial performance and excessive executive compensation despite stagnant shareholder returns. The Razin Group aims to revitalize governance and corporate strategy by replacing Margolis and other entrenched directors, advocating for shareholder rights and organic growth.